INS-IGF2
Basic information
Region (hg38): 11:2132538-2161209
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Maturity-onset diabetes of the young type 10 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the INS-IGF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 10 | 30 | 42 | |||
nonsense | 1 | |||||
start loss | 2 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 29 | 15 | 61 | |||
Total | 1 | 22 | 61 | 24 | 8 |
Variants in INS-IGF2
This is a list of pathogenic ClinVar variants found in the INS-IGF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-2132995-G-T | Likely benign (Apr 10, 2024) | |||
11-2133009-T-G | IGF2-related disorder | Uncertain significance (Feb 26, 2024) | ||
11-2133009-T-TG | Colorectal cancer | Pathogenic (-) | ||
11-2133011-T-G | Likely benign (Nov 01, 2024) | |||
11-2133011-TG-T | Uncertain significance (Apr 12, 2024) | |||
11-2133011-T-TG | Uncertain significance (Mar 09, 2024) | |||
11-2133012-G-A | Inborn genetic diseases | Uncertain significance (Dec 16, 2022) | ||
11-2133012-G-C | Uncertain significance (Oct 23, 2024) | |||
11-2133013-G-A | Uncertain significance (Nov 03, 2022) | |||
11-2133017-G-T | not specified | Likely benign (Jan 23, 2024) | ||
11-2133020-G-A | Likely benign (Dec 23, 2024) | |||
11-2133020-GC-G | not specified | Uncertain significance (Feb 19, 2024) | ||
11-2133025-C-A | Inborn genetic diseases | Conflicting classifications of pathogenicity (Nov 18, 2023) | ||
11-2133025-C-G | Inborn genetic diseases | Uncertain significance (Dec 19, 2021) | ||
11-2133026-G-A | Likely benign (Sep 10, 2023) | |||
11-2133027-T-G | Inborn genetic diseases | Uncertain significance (Jun 30, 2021) | ||
11-2133031-C-A | Inborn genetic diseases | Uncertain significance (Nov 28, 2024) | ||
11-2133031-C-T | Uncertain significance (Aug 20, 2024) | |||
11-2133034-G-T | IGF2-related disorder | Uncertain significance (Sep 16, 2024) | ||
11-2133035-G-C | Inborn genetic diseases | Uncertain significance (Aug 20, 2023) | ||
11-2133040-G-A | Likely pathogenic (Feb 01, 2021) | |||
11-2133050-A-G | IGF2-related disorder | Likely benign (Nov 11, 2024) | ||
11-2133057-AG-A | Uncertain significance (Nov 21, 2024) | |||
11-2133063-C-T | Benign (Jan 29, 2025) | |||
11-2133063-C-CG | Uncertain significance (Jun 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
INS-IGF2 | protein_coding | protein_coding | ENST00000397270 | 3 | 28672 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0558 | 0.873 | 125516 | 0 | 4 | 125520 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0114 | 91 | 91.3 | 0.997 | 0.00000569 | 1230 |
Missense in Polyphen | 25 | 24.773 | 1.0092 | 295 | ||
Synonymous | -0.724 | 49 | 43.0 | 1.14 | 0.00000279 | 457 |
Loss of Function | 1.51 | 3 | 7.43 | 0.404 | 4.36e-7 | 78 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- AMP-activated Protein Kinase (AMPK) Signaling;Type II diabetes mellitus
(Consensus)
Intolerance Scores
- loftool
- 0.314
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.12
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.386
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of signaling receptor activity
- Cellular component
- extracellular region
- Molecular function
- hormone activity